Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
- Posted on August 4, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
